Navigation Links
Top Medical Research Centers Form Velos Advisory Group for Service-Oriented Architecture
Date:6/4/2009

- Objectives Include Interoperability, Collaboration, Clinical Research Advancement -

SAN FRANCISCO, June 4 /PRNewswire/ -- The University of Texas M. D. Anderson Cancer Center, one of the nation's leading centers for cancer care and research, has been instrumental in establishing a Velos Advisory Group for Service-Oriented Architecture (SOA). Five other leading academic medical centers and research institutions have helped to form this group. These include Columbia University, Duke University, University of Kansas, University of Miami and UT Southwestern Medical Center. The Advisory Group will collaborate with Velos to create an SOA layer for the Velos eResearch clinical trial management system deployed at each of their respective institutions.

"At M. D. Anderson, we concluded early in this process that interoperability of Velos with a variety of legacy institutional applications, as well as National Cancer Institute (NCI) applications and resources, was a critical success factor for our research informatics initiatives," stated Roy B. Jones, Ph.D. M.D., Professor of Medicine, Chair, Clinical Research Computing Committee, M. D. Anderson Cancer Center. "For some time, we have pushed for the implementation of SOA as the preferred way of accomplishing this goal."

Dr. Jones led efforts to form the Advisory Group, conferring with other members who are at various stages of implementing Velos eResearch to support clinical trials management. Each member has demonstrated a significant interest in a service-oriented approach to the Velos implementation. It is intended that each institution's objectives be harmonized with those of Velos and with data standards such as those in the NCI's caDSR. This will help all members achieve the goal of interoperability.

SOA is a design approach that focuses on loosely-coupled interfaces connecting multiple software agents. An SOA infrastructure enables different software applications to exchange data with one another. Using SOA principles, organizations can create new, integrated or interoperating solutions leveraging systems and databases already in place.

"We are pleased at the formation of this Advisory Group and gratified to see institutions of such high stature as its charter members," said John S. McIlwain, President and CEO of Velos. "The Velos platform will be critical to strategic directions that include collaboration with other institutions on a national and international scale. This new application layer will allow integrated systems to be more efficient and reliable. SOA is a further step in solving the 'last mile' where the value of Direct Data Capture is realized and where it will occur in real time. Velos is fully committed to developing this capability."

About The University of Texas M.D. Anderson Cancer Center

Celebrating more than six decades of Making Cancer History(R), The University of Texas M. D. Anderson Cancer Center is located in Houston on the sprawling campus of the Texas Medical Center. It is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. M. D. Anderson Cancer Center was created by the Texas Legislature in 1941 as a component The University of Texas System. The institution is one of the nation's original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of 40 National Cancer Institute-designated comprehensive cancer centers today. In 2008, U.S. News & World Report's "America's Best Hospitals" survey ranked M.D. Anderson as the top hospital in the nation for cancer care. M.D. Anderson has achieved the top ranking four times in the past six years and has ranked as one of the top two hospitals for cancer care for 19 years, since the magazine began its annual survey in 1990.

About Velos

Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. The company serves 21 Top 25 U.S. medical centers. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to participate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Velos eTools, a companion product to Velos eResearch, empowers customers by giving them ownership and access to functions such as system configuration, data migrations, custom reporting and third party data submissions. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit www.velos.com.

This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.


'/>"/>
SOURCE Velos
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):